Clinical Trial: Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Initial Treatment of Patients With Immune Thrombocytopenic Purpura: The ITP^2 Study

Brief Summary: This study will compare treatment with 3 courses of high-dose dexamethasone versus treatment with prednisone, for patients recently diagnosed with immune thrombocytopenic purpura (ITP). The primary hypothesis is that patients treated with high-dose dexamethasone will obtain a more durable remission than patients treated with prednisone.